Published in:
Open Access
01-12-2012 | Case report
Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Authors:
Anna Färnert, Johan Ursing, Thomas Tolfvenstam, Josea Rono, Lillemor Karlsson, Elda Sparrelid, Niklas Lindegårdh
Published in:
Malaria Journal
|
Issue 1/2012
Login to get access
Abstract
Artemether-lumefantrine is currently first-line therapy of Plasmodium falciparum malaria in many countries. This report describes a treatment failure despite adequate drug concentrations in a traveller returning from sub-Saharan Africa. Genotyping confirmed recrudescence and suggested reduced sensitivity. Potential sub-optimal effect of artemether-lumefantrine highlights the need to follow non-immune individuals the weeks after treatment.